{"id":4419,"date":"2019-03-26T05:51:02","date_gmt":"2019-03-26T05:51:02","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4419"},"modified":"2019-11-12T15:25:16","modified_gmt":"2019-11-12T15:25:16","slug":"une-etude-sur-la-lenalidomide-dans-le-traitement-des-troubles-histiocytaires-chez-ladulte","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/fr\/study_trials\/a-study-of-lenalidomide-for-adult-histiocyte-disorders\/","title":{"rendered":"\u00c9tude sur la l\u00e9nalidomide dans le traitement des troubles histiocytaires chez l'adulte"},"content":{"rendered":"<p><strong>Objectif de l'\u00e9tude :<\/strong>&nbsp; Cette \u00e9tude de recherche est un essai clinique de phase II visant \u00e0 \u00e9valuer un m\u00e9dicament de chimioth\u00e9rapie, la l\u00e9nalidomide, en tant que traitement potentiel de l\u2019une des trois maladies histiocytaires suivantes : l\u2019histiocytose \u00e0 cellules de Langerhans (HCL), la maladie d\u2019Erdheim-Chester (MEC) ou le sarcome histiocytaire (SH).<\/p>\n<p><strong>Parrain :<\/strong>&nbsp; Institut de canc\u00e9rologie Dana-Farber<\/p>\n<p><strong>Coordonn\u00e9es pour l'essai :<\/strong>&nbsp; Dr Eric Jacobsen, 617-632-6633, edjacobsen@partners.org<\/p>\n<p><strong>Participation demand\u00e9e au patient :<\/strong> Patients \u00e2g\u00e9s de 18 ans et plus chez lesquels un ECD a \u00e9t\u00e9 diagnostiqu\u00e9.<\/p>\n<p><strong>Identifiant ClinicalTrials.gov :<\/strong> NCT02523040<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective:&nbsp; This research study is a Phase II clinical trial studying a chemotherapy drug Lenalidomide as a possible treatment for one of three histiocyte disorders: Langerhans cell histiocytosis (LCH), [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[32],"class_list":["post-4419","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-drug-trial"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials\/4419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/media?parent=4419"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials_cat?post=4419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}